Back
Splash Beverage Group Vs. Keros Therapeutics Industry Stock Comparison
Sell
39
SBEV
Splash Beverage Group
Last Price:
0.36
Seasonality Move:
125.66%
Sell
43
KROS
Keros Therapeutics
Last Price:
60.54
Seasonality Move:
-20.18%
Sell
39
Splash Beverage Group (SBEV)
is a Sell
Is Splash Beverage Group a Buy, Sell or Hold?
- The current Splash Beverage Group [SBEV] share price is $0.34. The Score for SBEV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SBEV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.57. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBEV Stock Price Chart
What is Splash Beverage Group's stock price today?
-
The Splash Beverage Group share price today is $0.34
The current trend is relatively stagnant and SBEV is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
SBEV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 44.94 | Sell |
| Chaikin Money Flow: | -28026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.32 - 0.36) | Buy |
| Bollinger Bands (100): | (0.36 - 0.58) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 52.59 | Buy |
| Chaikin Money Flow: | 191481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.41 - 62.79) | Buy |
| Bollinger Bands (100): | (45.59 - 66.39) | Buy |
SBEV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.33 | Buy |
| 20-day SMA: | 0.33 | Buy |
| 50-day SMA: | 0.44 | Sell |
| 200-day SMA: | 0.58 | Sell |
| 8-day EMA: | 0.33 | Buy |
| 20-day EMA: | 0.35 | Sell |
| 50-day EMA: | 0.4 | Sell |
| 200-day EMA: | 0.62 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.32 | Buy |
| 20-day SMA: | 58.53 | Buy |
| 50-day SMA: | 63.26 | Sell |
| 200-day SMA: | 44.75 | Buy |
| 8-day EMA: | 57.98 | Buy |
| 20-day EMA: | 58.88 | Buy |
| 50-day EMA: | 59.57 | Buy |
| 200-day EMA: | 50.24 | Buy |
Splash Beverage Group Earnings Growth & SBEV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.12 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Splash Beverage Group Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||